Similar Items: A contemporary overview of multiple endocrine neoplasia syndromes: MEN syndromes 1–5 and beyond
- Mast Cells in Myelodysplastic Syndromes
- Cancer Prevalence Among Large Cohort of Individuals With Down Syndrome: Implications for Screening Guidelines
- Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study
- Endocrine therapy‐induced cancer‐related fatigue in hormone‐dependent malignancies: Mechanisms, impact, and management strategies
- Adherence to oral antineoplastic agents, an overview and meta-analysis
- Synergistic Antitumor Activity of HAT Inhibitor A485 and XPO1 Inhibitor KPT8602 in Multiple Myeloma